This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Arena Pharma, Sunesis: Volume Movers

NEW YORK ( TheStreet) -- Arena Pharmaceuticals (ARNA - Get Report) was one of several stocks trading near $5 poised to move on above-average volume Thursday after the biopharmaceutical company announced a marketing agreement for its weight-loss drug.

Arena Pharmaceuticals said Eisai will market lorcaserin in the U.S. following approval from the Food and Drug Administration. Arena will receive an upfront payment of $50 million from Eisai and is eligible for up to an additional $90 million in milestone payments after regulatory approval and delivery of product supply.

Arena is also eligible to receive $1.16 billion in one-time purchase price adjustment payments based on annual sales levels of lorcaserin and up to an additional $70 million in regulatory and development milestone payments.

Shares of Arena Pharmaceuticals jumped by 63 cents, or 20.5%, to $3.70 in the premarket session. The 50-day average daily volume for Arena is 2.77 million, according to the Nasdaq.

Elsewhere, Alliance Fiber Optic Products (AFOP - Get Report) jumped by 16 cents, or 11.5%, to $1.55 in the premarket session after the fiber optic components manufacturer upped its second-quarter revenue guidance to $11.5 million from prior guidance of $10 million. The 50-day average daily volume for Alliance Fiber Optic is 105,000.

Smith & Wesson (SWHC - Get Report) shares rose by 16 cents, or 3.9%, to $4.25 in the premarket session after the firearms producer posted fourth-quarter adjusted earnings of 8 cents a share, doubling the Thomson Reuters average estimate. Sales of $103.8 million was also better than analysts had forecasted. The 50-day average daily volume for Smith & Wesson is 1.03 million.

On the other hand, Sunesis Pharmaceuticals (SNSS - Get Report) plunged by 10 cents, or 21.2%, to 37 cents in Wednesday's aftermarket session after the company said it had priced a $28.5 million offering of common stock at 27.5 cents per share. The 50-day average daily volume for Sunesis is 3.75 million.

Exelixis (EXEL - Get Report) slid by 29 cents, or 8.4%, to $3.18 after yesterday's closing bell after the cancer treatment developer said that Michael Morrissey has been promoted to President and CEO from his current position as President of Research and Development. Morrissey replaces George Scangos, who will leave the CEO position on July 15 to becomes head of Biogen Idec (BIIB). The 50-day average daily volume for is 1.46 million.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
AFOP $18.14 -2.16%
ARNA $4.21 -2.32%
CBK $6.01 0.33%
EXEL $2.86 -2.72%
NCT $5.38 -1.10%

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs